FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular opthalmology, and may be used for treating the patients with a "dry" form of age-related macular degeneration. That is combined with using lutein-containing antioxidants and carotenoids for one year every 2-3 months. Fenofibrate (Tricor 145) is additionally used for a period of time long enough to normalise a lipid profile and to maintain the above values at the attained level. Vitrum vision forte and nutrof total are used as the above lutein-containing antioxidants and carotenoids.
EFFECT: invention provides arresting the progression of the "dry" form of age-related macular degeneration.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO AGE-RELATED MACULAR DEGENERATION (AMD) | 2018 |
|
RU2707955C1 |
| METHOD FOR INHIBITING THE PROGRESSION OF THE "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION IN ELDERLY PATIENTS | 2020 |
|
RU2755890C1 |
| ATHEROSCLEROSIS NUTRITIVE PREVENTION AND TREATMENT METHOD | 2007 |
|
RU2360669C1 |
| METHOD OF TREATING PATIENTS SUFFERING WINTER-TYPE PLAQUE PSORIASIS OF MODERATE AND MILD SEVERITY | 2014 |
|
RU2567725C2 |
| APPLICATION OF DIETARY SUPPLEMENT PROVITAM AS LIPID PEROXIDATION INHIBITOR | 2008 |
|
RU2408382C2 |
| METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
| NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT | 2019 |
|
RU2806096C2 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2140236C1 |
| METHOD FOR TREATMENT OF NONPROLIFERATIVE STAGE OF DIABETIC RETHYOPATHY | 2016 |
|
RU2621873C1 |
| METHOD FOR DIAGNOSING AND PREDICTING CARDIAC ISCHEMIA DISEASE | 1999 |
|
RU2173853C2 |
